Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer
Authors:
Open Access
- 22 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 12
Abstract
Post-transcriptional regulation plays a leading role in gene regulation and RNA binding proteins (RBPs) are the most important posttranscriptional regulatory protein. RBPs had been found to be abnormally expressed in a variety of tumors and is closely related to its occurrence and progression. However, the exact mechanism of RBPs in bladder cancer (BC) is unknown. We downloaded transcriptomic data of BC from the Cancer Genome Atlas (TCGA) database and used bioinformatics techniques for subsequent analysis. A total of 116 differentially expressed RBPs were selected, among which 61 were up-regulated and 55 were down-regulated. We then identified 12 prognostic RBPs including CTIF, CTU1, DARS2, ENOX1, IGF2BP2, LIN28A, MTG1, NOVA1, PPARGC1B, RBMS3, TDRD1, and ZNF106, and constructed a prognostic risk score model. Based on this model we found that patients in the high-risk group had poorer overall survival (P < 0.001), and the area under the receiver operator characteristic curve for this model was 0.677 for 1 year, 0.697 for 3 years, and 0.709 for 5 years. Next, we drew a nomogram based on the risk score and other clinical variables, which showed better predictive performance. Our findings contribute to a better understanding of the pathogenesis, progression and metastasis of BC. The model of these 12 genes has good predictive value and may have good prospects for improving clinical treatment regimens and patient prognosis.Keywords
This publication has 60 references indexed in Scilit:
- Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer CellsPLOS ONE, 2012
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingBMC Cancer, 2011
- LIN28B Promotes Colon Cancer Progression and MetastasisCancer Research, 2011
- Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancerBreast Cancer Research, 2011
- Ribosomopathies: human disorders of ribosome dysfunctionBlood, 2010
- Lin28 promotes transformation and is associated with advanced human malignanciesNature Genetics, 2009
- Indolyl‐quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation‐mediated control of tumor vasculatureThe FASEB Journal, 2009
- RNA and DiseaseCell, 2009
- miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levelsProceedings of the National Academy of Sciences, 2008
- Transcription regulation and animal diversityNature, 2003